Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
29,36 USD | +1,87 % | +6,88 % | +272,12 % |
Resumen de negocios
Número de empleados: 45
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Herbert Cross
DFI | Director of Finance/CFO | 52 | 22/09/23 |
Luca Di Noto
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Wendy Pang
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Edwin Tucker
CTO | Chief Tech/Sci/R&D Officer | 52 | 12/06/23 |
Jeet Mahal
COO | Chief Operating Officer | 52 | 01/12/19 |
Matthew Ford
HRO | Human Resources Officer | - | 13/04/23 |
David Hinds
PRN | Corporate Officer/Principal | - | 10/04/23 |
Patricia Carlos
LAW | General Counsel | - | 02/08/23 |
Arjun Agarwal
AUD | Comptroller/Controller/Auditor | - | 01/01/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Thomas Wiggans
CHM | Chairman | 72 | 01/11 |
Kurt von Emster
BRD | Director/Board Member | 56 | 24/09/21 |
Scott Brun
BRD | Director/Board Member | 56 | 20/06/23 |
Vishal Kapoor
BRD | Director/Board Member | 48 | 16/02/23 |
Christian Nolet
BRD | Director/Board Member | 67 | 24/09/21 |
Anna Phil
BRD | Director/Board Member | 36 | 24/09/19 |
Judith Shizuru
FOU | Founder | 68 | 01/03/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 15 063 896 | 13 892 140 ( 92,22 %) | 0 | 92,22 % |
Información de la empresa
Jasper Therapeutics, Inc.
2200 Bridge Parkway Suite 102
94065, Redwood City
+
http://www.jaspertherapeutics.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+272,12 % | 434 M | |
+33,46 % | 701 mil M | |
+26,24 % | 571 mil M | |
+0,93 % | 381 mil M | |
+21,03 % | 334 mil M | |
+17,51 % | 319 mil M | |
+0,74 % | 210 mil M | |
+2,95 % | 210 mil M | |
-6,05 % | 201 mil M | |
-3,61 % | 157 mil M |
- Bolsa
- Acciones
- Acción Jasper Therapeutics, Inc. - Nasdaq
- Empresa Jasper Therapeutics, Inc.